News

NICE has worked with Option Grid and UK dermatologists Jason Thomson and Jane McGregor, to produce information for melanoma patients and their medical teams. The information is provided in the form of Option Grids which allow consideration of the potential advantages and disadvantages of given medical procedures or treatments.Read More

GenoMEL has some new information in the Information for Patients section, on a rare inherited genetic mutation which increases the risk of melanoma in some families. The appearance of the moles and the melanomas in these families can be unusual and affected families are also at increased risk ofRead More

NICE published the Clinical Melanoma Guideline in July 2015. This Guideline is directed at secondary and tertiary care (hospital treatment) in the UK and considers the role of treatments such as sentinel node biopsy. This is a link to the guideline http://www.nice.org.uk/guidance/ng14 The Guideline addressed the role of sentinel nodeRead More

NICE asked Professor Julia Newton-Bishop to discuss why vitamin D was considered by the Clinical Melanoma Guideline and this is the link to her podcast  Read More

We have updated the plain language summaries of GenoMEL research in the Information for Patients section. More to follow!Read More

The Journal of the National Cancer Institute has published a new GenoMEL paper examining the role of chromosomal telomere length in melanoma. The research involved creating a score representing genetically determined telomere length, based on all the established telomere associated genes and found that this score correlated with melanomaRead More